Amazon.com IncAmazon shares rose as investors weighed Anthropic's Claude misuse disclosure, with no company-specific driver beyond its Anthropic investment and AWS contract exposure.

Amazon.com gained about 1.6% to $255.77 Friday as investors weighed a fresh safety challenge involving Anthropic. The AI developer said it disrupted suspected misuse of Claude tied to biological research, weapons development and cyber operations, then tightened its defenses. Anthropic's threat-intelligence report detailed five cases involving research that could assist biological-weapons development, though it stopped short of claiming every researcher had harmful intent, and it also identified suspected state-linked cyber campaigns and work involving conventional weapons. Amazon has plenty at stake: its second-quarter results included $53.4 billion in non-operating pretax income, driven primarily by gains tied to its Anthropic investment, a figure roughly 3.2 times AWS's $16.62 billion in quarterly operating income. Anthropic has also committed to purchasing more than $100 billion of AWS computing capacity over ten years, turning the relationship into both a major investment and a massive cloud contract.
Amazon.com IncAmazon shares rose as investors weighed Anthropic's Claude misuse disclosure, with no company-specific driver beyond its Anthropic investment and AWS contract exposure.
Anthropic disclosed disrupted misuse of Claude tied to biological-weapons research, weapons development and cyber operations, forcing it to tighten defenses.